References
- Dandona P, Wollard M L, James I M, Newburry P, Beckett A G. Instability of cerebral blood flow in insulin-dependent diabetics. 1979; II: 1203–5
- Kohner E M, Hamilton A M, Saunders S J, Suttcliff B A, Bulpitt C J. The retinal blood flow and diabetes. Diabetologia 1975; 11: 27–33
- Gundersen H JG. Peripheral blood-flow and metabolic control in juvenile diabetes. Diabetologia 1974; 10: 225–31
- Christiansen J S, Gammelgaard J, Tronier B, Svendsen P A, Parving H-H. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683–8
- Thuesen L, Christiansen J S, Falstie-Jensen N, Christensen C K, Hermansen K, Mogensen C E, Henningsen P. Increased myocardial contractility in short-term type 1 diabetic patients. An echocardiographic study. Diabetologia 1985; 28: 822–6
- Mathiesen E R, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen N J, Parving H-H. Effect on metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985; 34: 1301–5
- Goldweit R S, Borer J S, Jovanovic L G, Drexler A J, Hochreiter C A, Devereux R B, Peterson C M. Relation of hemoglobin A1 and blood glucose to cardiac function in diabetes mellitus. Am J Cardiol 1985; 56: 642–6
- Muller W A, Faloona G R, Unger R H. Hyperglucagonemia in diabetic ketoacidosis. Am J Med 1973; 54: 52–7
- Farah A, Tuttle R. Studies on the pharmacology of glucagon. J Pharmacol Exp Ther 1960; 129: 49–55
- Glick G, Parmley W W, Wechsler A S, Sonnenblick EGlucagon H. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res 1968; 22: 789–99
- Ørskov H, Thomsen H G, Yde H. Wick-chromatography for rapid and reliable immunoassay of insulin glucagon and growth hormone. Nature 1968; 219: 193–5
- Feigenbaum H. Echocardiography, 3rd edn. Lea and Fibiger, Philadelphia 1981; 119–221
- Teichholz L E, Kreulen T, Herman M V, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7–11
- Reichek N, Wilson J, Sutton M SJ, Plappert T A, Goldberg S, Hirshfield J W. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982; 65: 99–108
- Quinones M A, Gaasch W H, Cole J S, Alexander J K. Echocardiographic determination of left ventricular stress-velocity relations in man. With reference to the effects of loading and contractility. Circulation 1975; 51: 689–700
- Ladipo G OA, Dunn F G, Pringle T H, Bastian B, Lawrie T DW. Serial measurements of left ventricular dimensions by echocardiography. Br Heart J 1980; 44: 284–9
- Clark R D, Korcusca K, Cohn K. Serial echocardiography evaluation of left ventricular function in valvular heart disease including reproducibility guidelines for serial studies. Circulation 1980; 62: 564–75
- Wallerson D C, Devereux R B. Reproducibility of quantitative echocardiography: factors affecting variability of imaging and doppler measurements. Echocardiography 1986; 3: 219–35
- Parmley W W, Glick G, Sonnenblick E H. Cardiovascular effects of glucagon in man. New Engl J Med 1968; 279: 12
- Armstrong P W, Gold H K, Dagger W M, Austen G, Sanders C A. Hemodynamic evaluation of glucagon in symptomatic heart disease. Circulation 1971; 44: 67–73
- Parving H-H, Noer J, Kehlet H, Mogensen C E, Svendsen P A, Heding L. The effect of short-term glucagon infusion on kidney function in normal man. Diabetologia 1977; 13: 323–5
- Parving H-H, Chrtistiansen J S, Noer I, Tronier B, Mogensen C E. The effect of glucagon infusion on kidney function in short-term insulin-dependent diabetic juvenile diabetics. Diabetologia 1980; 19: 350–4